How does Promise Pharmacy volume pricing work?

A volume model raises specific questions a clinic should resolve before signing. Ask whether your wholesale rate is tied to a minimum monthly commitment, what happens if you fall short, and whether better tiers require joining the Wholesale Program or white-label track. Ask whether the discounted rate is per SKU or blended across your order mix, since a strong GLP-1 rate can mask a weaker peptide line. And ask whether rates reset or renegotiate over time, because a launch wholesale rate that drifts upward changes margin after you have built patient pricing around it.

The harder issue with unpublished tiers is verification. Without public breakpoints, you cannot independently check whether the rate you receive reflects the volume you bring. That is not a reason to dismiss volume discounts — in-house compounding at scale can genuinely lower cost — but it is a reason to get the tier curve in writing for your SKUs rather than relying on a general volume-savings claim.

Fizy Health shows resolved per-vial 503A cost on each catalog and cart line before checkout, with a separately disclosed facilitation fee at payment — visible whether you are a new clinic or high-volume, and visible before you commit to any single compounder's volume program. Drug cost passes through from assigned 503A partners, so the number you see is the number you pay without waiting on tier negotiation.

For clinics still scaling, that removes a chicken-and-egg problem: you do not need volume to see a competitive price, and you do not need to commit to a wholesale tier before you know your cost. You can compare visible pass-through per-vial cost against any Promise Pharmacy volume rate on the exact SKUs you order most, and decide based on the landed number rather than the promise of a better tier later.